Development
Tharimmune, Inc.
THAR
$1.51
-$0.0001-0.01%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 13.38% | 1.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.18% | -21.97% | |||
| Operating Income | -37.18% | 21.97% | |||
| Income Before Tax | -35.92% | 22.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.92% | 22.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.92% | 22.11% | |||
| EBIT | -37.18% | 21.97% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 72.90% | 32.67% | |||
| Normalized Basic EPS | 72.90% | 32.67% | |||
| EPS Diluted | 72.90% | 32.67% | |||
| Normalized Diluted EPS | 72.90% | 32.67% | |||
| Average Basic Shares Outstanding | 401.43% | 15.69% | |||
| Average Diluted Shares Outstanding | 401.43% | 15.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||